141 related articles for article (PubMed ID: 9833632)
1. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.
Popik P; Mamczarz J; Fraczek M; Widła M; Hesselink M; Danysz W
Neuropharmacology; 1998 Aug; 37(8):1033-42. PubMed ID: 9833632
[TBL] [Abstract][Full Text] [Related]
2. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
Kotlińska J
Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
[TBL] [Abstract][Full Text] [Related]
4. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
5. Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats.
Bespalov AY; Medvedev IO; Sukhotina IA; Zvartau EE
Behav Pharmacol; 2001 Apr; 12(2):135-42. PubMed ID: 11396518
[TBL] [Abstract][Full Text] [Related]
6. Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine- and cocaine-induced place preference.
Kotlińska J; Biała G
Pol J Pharmacol; 1999; 51(4):323-30. PubMed ID: 10540964
[TBL] [Abstract][Full Text] [Related]
7. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.
Popik P; Skolnick P
Pharmacol Biochem Behav; 1996 Apr; 53(4):791-7. PubMed ID: 8801580
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Blokhina EA; Sukhotina IA; Bespalov AY
Eur J Pharmacol; 2000 Oct; 406(2):227-32. PubMed ID: 11020485
[TBL] [Abstract][Full Text] [Related]
9. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
Bristow LJ; Hogg JE; Hutson PH
Neuropharmacology; 1997 Feb; 36(2):241-50. PubMed ID: 9144662
[TBL] [Abstract][Full Text] [Related]
10. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
12. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.
Kosten TA; DeCaprio JL; Rosen MI
Neuropsychopharmacology; 1995 Dec; 13(4):323-33. PubMed ID: 8747757
[TBL] [Abstract][Full Text] [Related]
13. Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice.
Belozertseva IV; Danysz W; Bespalov AY
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):279-82. PubMed ID: 10731040
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor in nucleus accumbens is implicated in morphine withdrawal in rats.
Ji D; Sui ZY; Ma YY; Luo F; Cui CL; Han JS
Neurochem Res; 2004 Nov; 29(11):2113-20. PubMed ID: 15662845
[TBL] [Abstract][Full Text] [Related]
15. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
16. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
Medvedev IO; Dravolina OA; Bespalov AY
J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
[TBL] [Abstract][Full Text] [Related]
17. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
Popik P; Danysz W
J Pharmacol Exp Ther; 1997 Feb; 280(2):854-65. PubMed ID: 9023300
[TBL] [Abstract][Full Text] [Related]
19. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
20. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
